Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	16.09B
Revenue (ttm)	11.55B
Net Income (ttm)	1.04B
Shares Out	1.16B
EPS (ttm)	0.89
PE Ratio	15.60
Forward PE	13.14
Dividend	0.36 (2.56%)
Ex-Dividend Date	May 23, 2024

Volume	8,100,254
Average Volume	8,299,323
Open	13.62
Previous Close	13.96
Day's Range	13.62 - 13.99
52-Week Range	12.70 - 18.96
Beta	0.56
RSI	43.64
Earnings Date	Apr 18, 2025

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,060
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.